As of May 22
| +0.75 / +2.37%|
The 9 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 34.00, with a high estimate of 39.00 and a low estimate of 22.00. The median estimate represents a +5.10% increase from the last price of 32.35.
The current consensus among 9 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.